412016-31-0Relevant academic research and scientific papers
MTOR MODULATORS AND USES THEREOF
-
Paragraph 0327, (2016/01/30)
The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications.
Sulfamato hydroxamic acid metalloprotease inhibitor
-
, (2008/06/13)
A sulfamato hydroxamic acid compound that, inter alia, inhibits matrix metalloprotease (mmp) activity is disclosed as are a process for preparing the same, intermediate compounds useful in those syntheses, and a treatment process that comprises administering a contemplated sulfamato hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity.
